Grisanti Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-83,453
Closed -$5.94M 59
2016
Q4
$5.94M Sell
83,453
-96,261
-54% -$7.56M 2.67% 19
2016
Q3
$15.5M Sell
179,714
-4,324
-2% -$377K 7.51% 2
2016
Q2
$16M Sell
184,038
-4,693
-2% -$380K 8.82% 1
2016
Q1
$14.2M Sell
188,731
-3,205
-2% -$241K 6.66% 3
2015
Q4
$14.8M Sell
191,936
-14,415
-7% -$1.09M 6.57% 2
2015
Q3
$13.8M Buy
206,351
+4,731
+2% +$348K 5.49% 7
2015
Q2
$14.9M Sell
201,620
-5,704
-3% -$436K 5.58% 4
2015
Q1
$16.2M Buy
207,324
+129,949
+168% +$9.85M 6.05% 5
2014
Q4
$5.59M Buy
77,375
+10,370
+15% +$720K 2.1% 23
2014
Q3
$4.15M Buy
+67,005
New +$4.26M 1.68% 22

Other funds holding MDT

Grisanti Capital Management's MDT Position: Q1 2017 in Review

Grisanti Capital Management sold out of Medtronic (MDT) in Q1 2017, closing a stake of 83,453 shares — an estimated $5.94M sold.

Grisanti Capital Management first reported a position in MDT in Q3 2014 and held it in 10 quarters. The position peaked at $16.2M in Q1 2015. 1,283 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

  • Grisanti Capital Management reported no remaining Medtronic position as of Q1 2017 after selling out during the quarter.
  • Grisanti Capital Management sold 83,453 Medtronic shares in Q1 2017, an estimated $5.94M.
  • Grisanti Capital Management first reported a position in Medtronic in Q3 2014 and held it in 10 quarters.
  • Grisanti Capital Management's Medtronic position peaked at $16.2M in Q1 2015.
  • 1,283 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on Grisanti Capital Management's 13F filing for Q1 2017, filed 2 May 2017.